Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_assertion type Assertion NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_head.
- NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_assertion description "[In this study, we analyzed 320 thyroid tumors and six anaplastic carcinoma cell lines and detected BRAF mutations in 45 (38%) papillary carcinomas, two (13%) poorly-differentiated carcinomas, three (10%) anaplastic carcinomas, and five (83%) thyroid anaplastic carcinoma cell lines but not in follicular, H�rthle cell, and medullary carcinomas, follicular and H�rthle cell adenomas, or benign hyperplastic nodules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_provenance.
- NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_assertion evidence source_evidence_literature NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_provenance.
- NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_assertion SIO_000772 14602780 NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_provenance.
- NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_assertion wasDerivedFrom befree-2016 NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_provenance.
- NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_assertion wasGeneratedBy ECO_0000203 NP419502.RAW4Xi0JE1I_k7mcN09xdQ9dzCHhiLrYf1cf1myMlk6a4130_provenance.